Versor Investments’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31,500
Closed -$85.4K 261
2025
Q4
$85.4K Sell
31,500
-5,100
-14% -$16.7K 0.01% 586
2025
Q3
$155K Buy
+36,600
New +$161K 0.03% 598
2025
Q1
Sell
-11,700
Closed -$54.4K 808
2024
Q4
$54.4K Buy
+11,700
New +$64.3K 0.01% 724
2024
Q2
Sell
-70,139
Closed -$498K 802
2024
Q1
$498K Buy
70,139
+27,800
+66% +$184K 0.1% 333
2023
Q4
$284K Sell
42,339
-39,700
-48% -$224K 0.06% 545
2023
Q3
$462K Buy
82,039
+47,739
+139% +$318K 0.09% 340
2023
Q2
$189K Buy
34,300
+10,000
+41% +$53.8K 0.03% 556
2023
Q1
$152K Buy
24,300
+5,171
+27% +$28.8K 0.02% 661
2022
Q4
$89.1K Buy
+19,129
New +$94.2K 0.01% 680
2022
Q3
Sell
-117,829
Closed -$698K 856
2022
Q2
$698K Buy
117,829
+91,698
+351% +$1.02M 0.03% 370
2022
Q1
$505K Buy
+26,131
New +$599K 0.02% 330
2021
Q4
Sell
-6,529
Closed -$268K 579
2021
Q3
$268K Buy
+6,529
New +$237K 0.01% 409

Other funds holding GDRX

Versor Investments's GDRX Position: Q1 2026 in Review

Versor Investments sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 31,500 shares — an estimated $85.4K sold.

Versor Investments first reported a position in GDRX in Q3 2021 and held it in 12 quarters. The position peaked at $698K in Q2 2022. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Versor Investments reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 31,500 GoodRx Holdings shares in Q1 2026, an estimated $85.4K.
  • Versor Investments first reported a position in GoodRx Holdings in Q3 2021 and held it in 12 quarters.
  • Versor Investments's GoodRx Holdings position peaked at $698K in Q2 2022.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.